PDS Biotechnology Corp Basic Shares Outstanding (Weighted Average)
PDS Biotechnology Corp (PDSB) reported Basic Shares Outstanding (Weighted Average) of 55.66 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- PDS Biotechnology Corp weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 55.66M shares, a 21.26% increase year-over-year.
- PDS Biotechnology Corp weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 55.50M shares, a 36.96% increase year-over-year.
- PDS Biotechnology Corp weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 51.59M shares, a 37.62% increase year-over-year.
- PDS Biotechnology Corp weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 46.87M shares, a 27.34% increase year-over-year.
- PDS Biotechnology Corp weighted average number of shares outstanding, basic for fiscal 2025 was 46.38M shares, a 27.25% increase from fiscal 2024.
- PDS Biotechnology Corp weighted average number of shares outstanding, basic for fiscal 2024 was 36.45M shares, a 17.77% increase from fiscal 2023.
- PDS Biotechnology Corp weighted average number of shares outstanding, basic for fiscal 2023 was 30.95M shares, a 8.23% increase from fiscal 2022.
- PDS Biotechnology Corp weighted average number of shares outstanding, basic for fiscal 2022 was 28.60M shares, a 11.73% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 55.66M shares 10-Q · filed 2026-08-13 | 55.66M shares 10-Q · filed 2026-08-13 | 54.25M shares derived: average of 3 quarters · filed 2026-08-13 | 52.40M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | 55.50M shares 10-Q · filed 2026-05-14 | 53.54M shares derived: average of 2 quarters · filed 2026-05-14 | 51.32M shares derived: average of 3 quarters · filed 2026-05-14 | 49.96M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | 51.59M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 49.23M shares derived: average of 2 quarters · filed 2026-03-30 | 48.12M shares derived: average of 3 quarters · filed 2026-08-13 | 46.38M shares 10-K · filed 2026-03-30 |
| 2025-09-30 | 46.87M shares 10-Q · filed 2025-11-13 | 46.39M shares derived: average of 2 quarters · filed 2026-08-13 | 44.65M shares 10-Q · filed 2025-11-13 | 42.70M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | 45.90M shares 10-Q · filed 2026-08-13 | 43.23M shares 10-Q · filed 2026-08-13 | 41.30M shares derived: average of 3 quarters · filed 2026-08-13 | 40.18M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | 40.52M shares 10-Q · filed 2026-05-14 | 39.00M shares derived: average of 2 quarters · filed 2026-05-14 | 38.27M shares derived: average of 3 quarters · filed 2026-05-14 | 37.88M shares derived: average of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | 37.49M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 37.15M shares derived: average of 2 quarters · filed 2026-03-30 | 37.00M shares derived: average of 3 quarters · filed 2026-03-30 | 36.45M shares 10-K · filed 2026-03-30 |
| 2024-09-30 | 36.81M shares 10-Q · filed 2025-11-13 | 36.75M shares derived: average of 2 quarters · filed 2025-11-13 | 36.11M shares 10-Q · filed 2025-11-13 | 34.99M shares derived: average of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | 36.69M shares 10-Q · filed 2025-08-13 | 35.75M shares 10-Q · filed 2025-08-13 | 34.39M shares derived: average of 3 quarters · filed 2025-08-13 | 33.52M shares derived: average of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | 34.82M shares 10-Q · filed 2025-05-14 | 33.24M shares derived: average of 2 quarters · filed 2025-05-14 | 32.46M shares derived: average of 3 quarters · filed 2025-05-14 | 32.05M shares derived: average of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | 31.66M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 31.29M shares derived: average of 2 quarters · filed 2025-03-27 | 31.12M shares derived: average of 3 quarters · filed 2025-03-27 | 30.95M shares 10-K · filed 2025-03-27 |
| 2023-09-30 | 30.91M shares 10-Q · filed 2024-11-14 | 30.86M shares derived: average of 2 quarters · filed 2024-11-14 | 30.72M shares 10-Q · filed 2024-11-14 | 30.29M shares derived: average of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | 30.80M shares 10-Q · filed 2024-08-13 | 30.62M shares 10-Q · filed 2024-08-13 | 30.09M shares derived: average of 3 quarters · filed 2024-08-13 | 29.68M shares derived: average of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | 30.43M shares 10-Q · filed 2024-05-15 | 29.73M shares derived: average of 2 quarters · filed 2024-05-15 | 29.31M shares derived: average of 3 quarters · filed 2024-05-15 | 29.09M shares derived: average of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | 29.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 28.75M shares derived: average of 2 quarters · filed 2024-03-28 | 28.65M shares derived: average of 3 quarters · filed 2024-03-28 | 28.60M shares 10-K · filed 2024-03-28 |
| 2022-09-30 | 28.46M shares 10-Q · filed 2023-11-14 | 28.46M shares derived: average of 2 quarters · filed 2023-11-14 | 28.45M shares 10-Q · filed 2023-11-14 | 27.89M shares derived: average of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | 28.45M shares 10-Q · filed 2023-08-14 | 28.45M shares 10-Q · filed 2023-08-14 | 27.69M shares derived: average of 3 quarters · filed 2023-08-14 | 27.88M shares derived: average of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | 26.16M shares 10-Q · filed 2023-05-15 | 27.32M shares derived: average of 2 quarters · filed 2023-05-15 | 27.69M shares derived: average of 3 quarters · filed 2023-05-15 | 26.55M shares derived: average of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | 28.47M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | 28.45M shares derived: average of 2 quarters · filed 2023-03-28 | 26.69M shares derived: average of 3 quarters · filed 2023-03-28 | 25.60M shares 10-K · filed 2023-03-28 |
| 2021-09-30 | 28.43M shares 10-Q · filed 2022-11-14 | 25.79M shares derived: average of 2 quarters · filed 2022-11-14 | 24.64M shares 10-Q · filed 2022-11-14 | 24.04M shares derived: average of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | 23.16M shares 10-Q · filed 2022-08-08 | 22.71M shares 10-Q · filed 2022-08-08 | 22.58M shares derived: average of 3 quarters · filed 2022-08-08 | 21.67M shares derived: average of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | 22.26M shares 10-Q · filed 2022-05-11 | 22.28M shares derived: average of 2 quarters · filed 2022-05-11 | 21.18M shares derived: average of 3 quarters · filed 2022-05-11 | 19.72M shares derived: average of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | 22.30M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 20.63M shares derived: average of 2 quarters · filed 2022-03-31 | 18.87M shares derived: average of 3 quarters · filed 2022-03-31 | 16.75M shares 10-K · filed 2022-03-31 |
| 2020-09-30 | 18.96M shares 10-Q · filed 2021-11-10 | 17.16M shares derived: average of 2 quarters · filed 2021-11-10 | 14.89M shares 10-Q · filed 2021-11-10 | |
| 2020-06-30 | 15.36M shares 10-Q · filed 2021-08-12 | 12.84M shares 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | 10.31M shares 10-Q · filed 2021-05-13 | |||
| 2019-09-30 | 5.25M shares 10-Q · filed 2019-11-07 | 5.21M shares derived: average of 2 quarters · filed 2020-08-13 | 4.73M shares 10-Q · filed 2019-11-07 | |
| 2019-06-30 | 5.18M shares 10-Q · filed 2020-08-13 | 4.47M shares 10-Q · filed 2020-08-13 | ||
| 2019-03-31 | 3.75M shares 10-Q · filed 2020-05-13 | |||
| 2018-09-30 | 3.35M shares 10-Q · filed 2019-11-07 | 3.34M shares derived: average of 2 quarters · filed 2019-11-07 | 3.25M shares 10-Q · filed 2019-11-07 | |
| 2018-06-30 | 3.34M shares 10-Q · filed 2019-08-01 | 3.17M shares 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | 3.10M shares 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |